Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL100P (RNA, 7SL, cytoplasmic 100, pseudogene) is a human pseudogene related to the canonical 7SL RNA, which is a noncoding RNA component of the signal recognition particle (SRP)[4][6]. The 7SL RNA itself plays an essential role in protein targeting to membranes, but RN7SL100P is categorized as a pseudogene—a genomic sequence resembling 7SL RNA that has been incorporated into DNA likely via retrotransposition and is typically nonfunctional for canonical SRP activity[3][6]. Most 7SL-derived pseudogenes, including RN7SL100P, are truncated or mutated forms and are not expressed as functional RNAs or proteins[3][6]. There is no evidence that RN7SL100P is a receptor, enzyme, transporter, or any other typical therapeutic target, nor is it involved in any known disease role, biological function, or drug interactions[4][6]. The presence of multiple 7SL pseudogenes in the genome reflects the evolutionary history of repeats and retroelements, but they do not participate in signal transduction or clinical biomarker applications[3][6]. No information is available regarding RN7SL100P as a safety concern or therapeutic challenge.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 100, pseudogene (RN7SL100P).